Patents by Inventor Shaoxi KE

Shaoxi KE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance
    Patent number: 11612634
    Abstract: Disclosed are a pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance. The pharmaceutical composition includes a therapeutically effective amount of a short peptide and morphine as active ingredients, and a pharmaceutically-acceptable carrier. The short peptide is a peptide consisting of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically-acceptable salt thereof. In the method, the short peptide and morphine are administered to a subject simultaneously; or the short peptide is injected to the subject followed by administration of the morphine; or a pharmaceutical composition including the short peptide and morphine is administered to the subject.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: March 28, 2023
    Assignee: XUZHOU MEDICAL UNIVERSITY
    Inventors: Qiongyao Tang, Zhe Zhang, Chen Chen, Mingxi Tang, Yue Teng, Nan Zhou, Shaoxi Ke, Ping Dong, Jingjing Wang, Wanxin Su, Xiaohui Wang, Yanmei Xiao, Su Liu, Long Ma, Jun Gan, Xiaoxia Zhu, Sibei Ruan, Feng Ling
  • Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance
    Publication number: 20220168382
    Abstract: Disclosed are a pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance. The pharmaceutical composition includes a therapeutically effective amount of a short peptide and morphine as active ingredients, and a pharmaceutically-acceptable carrier. The short peptide is a peptide consisting of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically-acceptable salt thereof. In the method, the short peptide and morphine are administered to a subject simultaneously; or the short peptide is injected to the subject followed by administration of the morphine; or a pharmaceutical composition including the short peptide and morphine is administered to the subject.
    Type: Application
    Filed: December 13, 2021
    Publication date: June 2, 2022
    Inventors: Qiongyao TANG, Zhe ZHANG, Chen CHEN, Mingxi TANG, Yue TENG, Nan ZHOU, Shaoxi KE, Ping DONG, Jingjing WANG, Wanxin SU, Xiaohui WANG, Yanmei XIAO, Su LIU, Long MA, Jun GAN, Xiaoxia ZHU, Sibei RUAN, Feng LING